191 related articles for article (PubMed ID: 1980424)
1. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
2. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein.
Buschman E; Gros P
Cancer Res; 1994 Sep; 54(18):4892-8. PubMed ID: 7915194
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA.
Schurr E; Raymond M; Bell JC; Gros P
Cancer Res; 1989 May; 49(10):2729-33. PubMed ID: 2565763
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance mediated by P-glycoproteins.
Schinkel AH; Borst P
Semin Cancer Biol; 1991 Aug; 2(4):213-26. PubMed ID: 1680493
[TBL] [Abstract][Full Text] [Related]
6. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
Devault A; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
[TBL] [Abstract][Full Text] [Related]
7. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
8. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
9. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.
Raymond M; Rose E; Housman DE; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1642-51. PubMed ID: 1969609
[TBL] [Abstract][Full Text] [Related]
10. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
11. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
13. Isolation and expression of a complementary DNA that confers multidrug resistance.
Gros P; Ben Neriah YB; Croop JM; Housman DE
Nature; 1986 Oct 23-29; 323(6090):728-31. PubMed ID: 3022150
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
Nieuwint AW; Baas F; Wiegant J; Joenje H
Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity.
Teeter LD; Eckersberg T; Tsai Y; Kuo MT
Cell Growth Differ; 1991 Sep; 2(9):429-37. PubMed ID: 1661134
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes.
Buschman E; Gros P
Mol Cell Biol; 1991 Feb; 11(2):595-603. PubMed ID: 1990275
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene.
Hammond JR; Johnstone RM; Gros P
Cancer Res; 1989 Jul; 49(14):3867-71. PubMed ID: 2736530
[TBL] [Abstract][Full Text] [Related]
19. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
